Field Trip Health Ltd. to Pursue Treatment Resistant Depression and Postpartum Depression as Indications for FT-104 Sep 9, 2021
MYND Life Sciences Announces Closing of Fully Subscribed $3 Million Convertible Debenture Unit Offering Sep 9, 2021
Mydecine Innovations Group Announces MYCO-001 Seamless Phase 2/3 Smoking Cessation Clinical Trial Sep 7, 2021
MindMed and BioXcel Therapeutics Publish an International Patent Application Describing a System for Identifying… Sep 2, 2021
Red Light Holland Successfully Completes Canada’s Largest Legal Sale and Import of Psilocybe Truffles into Canada… Sep 1, 2021
Field Trip Health Ltd. Announces Launch Of “Kap Co-Operative” Program, Enabling Independent Psychedelic Therapists To… Aug 31, 2021
Mindset Pharma Announces its Next Generation Novel 5-MeO-DMT Psychedelic Analogs Demonstrate a Significantly Improved… Aug 31, 2021
